Principal Investigator:
Glasky, Alvin J , Principal Investigator
Award Amount:
$478,811.00
We will develop ait-082 for the treatment of dementia due to alzheimer's disease, stroke or aging. in phase i, we plan to complete the preclinical studies needed to submit an investigation- al new drug (ind) exemption application to the food and drug administration (fda). specifically, we will: (1)…
More